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Abstract
BackgroundSurgery has been the standard therapy for secundum 
atrial septal defect (ASD) closure, but it has significant associated 
morbidities related to sternotomy, cardiopulmonary bypass, 
complications, residual scars, and trauma. A less invasive non-
surgical approach with transcatheter devices was developed to 
occlude ASD. Amplatzer® septal occluder (ASO) is a common 
device in transcatheter closure. 
Objective To compare two secundum ASD closure procedures, 
transcatheter closure by ASO and surgical closure, in terms of 
efficacy, complications, length of hospital stay, and total costs. 
Methods A retrospective analysis was performed on children 
with secundum ASD admitted to the Cardiology Center of 
&LSWR0DQJXQNXVXPR+RVSLWDOIURP-DQXDU\WR'HFHPEHU
3DWLHQWVUHFHLYHGHLWKHUWUDQVFDWKHWHUFORVXUHZLWK$62
or surgical closure procedures. Data was obtained from patients’ 
medical records. 
Results $WRWDORIVHFXQGXP$6'FDVHVZHUHLQFOXGHGLQWKLV
VWXG\FRQVLVWLQJRIVXEMHFWVZKRXQGHUZHQWWUDQVFDWKHWHUFORVXUH
SURFHGXUHE\$62DQGVXEMHFWVZKRXQGHUZHQWVXUJLFDOFORVXUH
procedure. Procedure efficacies of surgery and ASO were not signifi-
FDQWO\GLIIHUHQWYVUHVSHFWLYHO\3 +RZHYHU
VXEMHFWVZKRXQGHUZHQWVXUJLFDOSURFHGXUHVKDGVLJQLILFDQWO\PRUH
FRPSOLFDWLRQVWKDQVXEMHFWVZKRXQGHUZHQWWUDQVFDWKHWHUFORVXUH
SURFHGXUHYVUHVSHFWLYHO\25&,WR
3 +RVSLWDOVWD\VZHUHDOVRVLJQLILFDQWO\ORQJHUIRU
surgical patients than for transcatheter closure patients (6 days vs 
GD\VUHVSHFWLYHO\3,QDGGLWLRQDOOVXUJLFDOVXEMHFWV
required intensive care. Transcatheter closure had a mean total cost 
RI6') million Rupiahs while the mean cost of surgery was 
6' PLOOLRQ5XSLDKV36LQFHWKH$62GHYLFH
FRVWUHSUHVHQWHGRIWKHWRWDOFRVWRIWUDQVFDWKHWHUFORVXUHWKH
mean cost of transcatheter closure procedure without the device 
itself was less costly than surgery. 
From the Department of Child Health, University of Indonesia Medical
School, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Reprint requests to: Mazdar Helmy, Department of Child Health, 
University of Indonesia Medical School, Cipto Mangunkusumo Hospital, 
-O'LSRQHJRUR-DNDUWD7HO(PDLOrheza80@
gmail.com
A
trial septal defect (ASD) is a common form of 
FRQJHQLWDOKHDUWGLVHDVHDFFRXQWLQJIRU
RIFRQJHQLWDOFDUGLDFGHIHFWVRIZKLFKLV
secundum ASD. Surgery has become the standard 
therapy for secundum ASD closure procedure, with 
low mortality rates and excellent survival in long term 
follow-up. However, surgery has significant morbidity 
related to sternotomy, cardiopulmonary bypass, 
residual scars, trauma, and other complications.3,4
Children undergoing cardiac procedures typically have 
Conclusion Transcatheter closure using ASO has a similar ef-
ILFDF\WRWKDWRIVXUJLFDOFORVXUHSURFHGXUH+RZHYHUVXEMHFWVZKR
underwent transcatheter closure have lower complication rates 
DQGVKRUWHUOHQJWKRIKRVSLWDOVWD\VWKDQVXEMHFWVZKRKDGVXUJHU\
but transcatheter closure costs are higher compared to the surgical 
procedure. [Paediatr Indones. 2013;53:108-16.].
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maldevelopment of the chest wall because of altered 
size and position of the underlying cardiac chambers, 
possibly leading to future breast and pectoral muscle 
maldevelopment.5
Non-surgical and less invasive approaches with 
transcatheter devices were developed to occlude 
secundum ASD. Amplatzer® septal occluder (ASO)
is one of the most widely used devices in transcatheter 
closure procedure. In Indonesia, transcatheter 
closure of secundum ASD has been performed in 
Cipto Mangunkusumo Hospital (CMH), Jakarta, 
VLQFHIROORZHGE\RWKHUFDUGLRORJ\FHQWHUV
VXFKDV6DUGMLWR+RVSLWDO<RJ\DNDUWDDQG6RHWRPR
Hospital, Surabaya. All centers reported that 
transcatheter closure using ASO have had excellent 
complete closure rates and can be used with few 
complications.
We aimed to compare two secundum ASD clo-
sure procedures, transcatheter closure using ASO and 
surgical closure, in terms of efficacies, complications, 
lengths of hospital stay, and total costs.
Methods
This was a retrospective analysis study on children 
DJHG\HDUVZLWKVHFXQGXP$6'DQGDGPLWWHG
WRWKH&DUGLRORJ\&HQWHURI&0+IURP-DQXDU\
WR'HFHPEHU6XEMHFWVKDGUHFHLYHGHLWKHU
transcatheter closure using ASO or surgical repair, 
and were grouped accordingly. The inclusion criteria 
was the presence of secundum ASD with a large left-
WRULJKWVKXQW4S4V!:HH[FOXGHGSDWLHQWV
with other congenital cardiac anomalies, other ASD 
(primum, sinus venosus, or sinus coronarius), partial 
anomalous pulmonary venous drainage, any type of 
serious infection prior to the procedure, or malignancy. 
:HFROOHFWHGWKHIROORZLQJGDWDIURPVXEMHFWV·PHGLFDO
records: demographic characteristics, baseline clinical 
data, success and complication rates, lengths of 
hospital stay, and total cost of procedure. 
The Amplatzer® septal occluder consists of 
two expandable round discs, with a 4-mm long 
FRQQHFWLQJZDLVWDQGPDGHRILQFK
Nitinol wire. The prothesis is filled with polyester 
mesh to facilitate thrombosis. The device size ranges 
IURPPPA detailed description of the 
transcatheter closure technique has been reported 
previously. The device is typically collapsed into 
a delivery catheter and delivered through a long 
sheath positioned in the left atrium after percutaneous 
entry of the femoral vein. Under fluoroscopic and 
transesophageal echocardiographic (TEE) guidance, 
both discs of the device are deployed across the defect, 
and then released.
Surgery typically involves general anesthesia with 
the aid of a cardiopulmonary bypass (CPB) machine. 
The right atrium is usually opened after median 
thoracotomy or anterolateral right thoracotomy. The 
defect is then closed either by direct suture or by 
pericardial patch.
Treatment success was determined on the basis 
of transthoracic echocardiography immediately after 
procedure (for transcatheter closure) and at 24-hours 
after the procedure or at the time of discharge from 
KRVSLWDOIRUERWKJURXSV6XEMHFWVZHUHFRQVLGHUHGWR
have successful ASD closure if they had no or trivial 
PPFRORUMHWZLGWKRUVPDOOFRORUMHWZLGWK
PPUHVLGXDOVKXQWV6XEMHFWVZLWKPRGHUDWH
FRORUMHWZLGWKPPRUODUJHFRORUMHWZLGWK!
mm) residual shunts, those who had reintervention 
procedures or those who died were considered to have 
failed procedures.
Complications were defined as untoward 
consequences of the closure procedure, either 
during the procedure or within 24 hours after the 
SURFHGXUHXQWLOWKHVXEMHFWZDVGLVFKDUJHGIURPWKH
KRVSLWDOSRVWSURFHGXUH0DMRUFRPSOLFDWLRQVZHUH
defined as life-threatening, or requiring immediate 
intervention or invasive treatment, such as cerebral 
embolism, cardiac perforation, pericardial effusion, 
pneumothorax or pleural effusion requiring drainage, 
arrhythmias requiring pacemaker or cardioversion, 
device embolization requiring surgical removal, or 
death due to the procedure. Minor complications were 
defined as requiring only conservative treatment, such 
as device embolization with percutaneous retrieval, 
arrhythmias with medical treatment, fever or wound 
complications.
Length of hospital stay was defined as the total 
KRVSLWDOVWD\UHTXLUHGIRUHDFKVXEMHFWIURPWKHWLPH
of admission for the ASD closure procedure until the 
VXEMHFWZDVGLVFKDUJHGIURPWKHKRVSLWDO
Total costs of procedures were calculated by 
summing patient charges for procedure  operating 
theatre, equipment usage, pharmacy, blood products, Mazdar Helmy et al: Comparison of surgical vs. non-surgical closure procedures for secundum atrial septal defect
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ASO device, supporting examinations (laboratory 
and radiology investigations, electrocardiography, and 
echocardiography), hospital stay, and medical fees. 
Cost-minimization analysis was used to compare the 
total costs between the two procedures. Non-medical 
or indirect costs were not taken into account.
Measured variables are described as proportion, 
mean (standard deviation) or median and range, as 
appropriate. Differences between continuous data 
were assessed by independent t-test or Mann-Whitney 
U test as appropriate, while differences between 
binary data were assessed by using chi-square test or 
)LVKHU·VH[DFWWHVWDVDSSURSULDWH$3YDOXH
was considered to be statistically significant. 
Results
$WRWDORIVXEMHFWVZLWKVHFXQGXP$6'ZHUH
enrolled in the study. Figure 1 shows the patient 
IORZGLDJUDPIRUHQUROOPHQW7KHUHZHUHVXEMHFWV
ZKRXQGHUZHQWWUDQVFDWKHWHUFORVXUHDQGVXEMHFWV
who underwent surgical repair. Table 1 shows the 
demographic and baseline clinical data for each group. 
0RVWVXEMHFWVZHUHXQGHUQRXULVKHGDQGWKHPRVW
common clinical manifestations in both groups were 
failure to thrive, respiratory infection, and exercise 
intolerance.
/DUJHUPHGLDQ$6'GLDPHWHUZDVVHHQLQVXEMHFWV
ZKRXQGHUZHQWVXUJLFDOFORVXUH>PHGLDQPP@
FRPSDUHGWRVXEMHFWVZKRXQGHUZHQWWUDQVFDWKHWHU
FORVXUH>PHGLDQPP@3 7KH
degree of left-to-right-shunting was comparable in 
ERWKJURXSV4S4V!7KHPHGLDQSURFHGXUH
GXUDWLRQIRUVXEMHFWVZKRXQGHUZHQWWUDQVFDWKHWHU
FORVXUHGLGQRWVWDWLVWLFDOO\GLIIHUHQWZLWKVXEMHFWVZKR
XQGHUZHQWVXUJLFDOFORVXUH>UDQJHPLQ
YVUDQJHPLQUHVSHFWLYHO\3 @
+RZHYHUWKHPHGLDQGXUDWLRQRIDQHVWKHVLDIRUVXEMHFWV
who underwent transcatheter closure was shorter 
WKDQWKDWRIVXEMHFWVZKRXQGHUZHQWVXUJLFDOFORVXUH
>UDQJHPLQYVUDQJHPLQ
UHVSHFWLYHO\3 @,QWUDQVFDWKHWHUFORVXUHWKH
VL]HRIGHYLFHVXVHGUDQJHGIURPWRPPPHGLDQ
PPDQGLQWKHVXUJLFDOFORVXUHVXEMHFWVPRVW
XQGHUZHQWFRQYHQWLRQDOWKRUDFRWRP\2QO\RI
VXEMHFWVKDGDQWHURODWHUDOULJKWWKRUDFRWRP\DQGPRVW
of them were female.
Figure 1. Flow diagram of subject enrollment to the study
188 children with secundum ASD 
 21 cases with other congenital cardiac 
anomalies
 3 cases under observation, no 
intervention 
 38 medical records were not found 
84 cases  
surgical closure 
42 cases 
transcatheter closure using ASO 
14 cases with mitral valve anomaly, 
need another surgical procedure
Analysis
70 cases  
surgical group 
42 cases  
ASO group Mazdar Helmy et al: Comparison of surgical vs. non-surgical closure procedures for secundum atrial septal defect
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2XWRIVXEMHFWVLQWKHWUDQVFDWKHWHUFORVXUH
JURXSVXEMHFWVKDGFRPSOHWHFORVXUHDQG
VXEMHFWVKDGDVPDOOUHVLGXDOVKXQWDWWKH
evaluation immediately after the procedure. In one 
VXEMHFWWKHDWWHPSWWRGHSOR\GHYLFHIDLOHG7KH
VXEMHFWRULJLQDOO\KDGDPP$6'GLDPHWHUDV
measured by precatheterization TEE (balloon stretched 
diameter), but after the device failed to deploy, the 
VXEMHFWXQGHUZHQWUHLQWHUYHQWLRQZLWKVXUJHU\'XULQJ
VXUJHU\WKH$6'GLDPHWHUZDVIRXQGWREHPPDQG
the defect was closed by direct suture.
At the 24-hour follow up or at the time of hospi-
WDOGLVFKDUJHVXEMHFWVLQWKHWUDQVFDWKHWHU
closure group had successful ASD closure (Table 2).
2QHVXEMHFWKDGGHYLFHPLJUDWLRQDWKRXUVDIWHU
the procedure, so he underwent surgical removal of 
the device and surgical closure. In the surgical closure 
JURXSVXEMHFWVKDGVXFFHVVIXO$6'FORVXUH
Table 1. Demographic and baseline clinical data
Characteristics
Procedures
Surgery (n = 70) ASO (n = 42)
Median age (range), years      7.7 (1-17.9)     6.6 (1.7-17.9)
Gender, n (%) 
Male
Female
  28    (40)
  42    (60)
    6    (14)
  36    (86)
Median weight (range), kg    18.5 (6.3-66)   18.7 (10.7-54)
Median height (range), cm  117.3 (66-170) 119    (85-160)
Nutritional status, n (%)
Well-nourished
Undernourished
  23    (33)
  47    (67)
  19    (45)
  23    (55)
Clinical manifestations, n (%)
&KHſEWNV[DTGCVJKPI
Failure to thrive
Respiratory infection
Exercise intolerance
Asymptomatic
Ejection murmur
9KFGſZGFURNKVQPnd heart sound
Pulmonary hypertension
Other
  16    (23)
  37    (53)
  38    (54)
  22    (31)
    9    (13)
  69    (99)
  47    (67)
  40    (57)
    8    (11)
    5    (12)
  17    (41)
  28    (67)
  10    (24)
    5    (12)
  39    (93)
  31    (74)
  14    (33)
    3      (7)
:TC[ſPFKPIUP

Cardiomegaly
Prominent pulmonary conus
Increased pulmonary vascularity
  42    (61)
  25    (36)
  35    (50)
  11    (26)
    6    (14)
    8    (19)
'NGEVTQECTFKQITCOſPFKPIUP

Right bundle branch block
Right axis deviation
Right ventricle enlargement
  23    (33)
  35    (50)
  42    (60)
    6    (14)
  13    (31)
  20    (48)
Table 2%QORCTKUQPQHGHſECE[DGVYGGPUWTIKECNENQUWTGCPFVTCPUECVJGVGTENQUWTGCVVJGJQWT
follow-up or at the time of hospital discharge
Defect closure
Procedures
P value
Surgery (n = 70) ASO (n = 42)
Successful, n (%)
No residual shunt
Trivial residual shunt
Small residual shunt
69 (99)
66 (95)
  1 (1)
  2 (3)
40 (95)
40 (95)
  0 (0)
  0 (0)
0.555
Failed, n (%)
Moderate residual shunt
Large residual shunt
Reintervention
Death
  1 (1)
  0 (0)
  0 (0)
  1 (1)
  0 (0)
  2 (5)
  0 (0)
  0 (0)
  2 (5)
  0 (0)Mazdar Helmy et al: Comparison of surgical vs. non-surgical closure procedures for secundum atrial septal defect
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5HRSHUDWLRQZDVUHTXLUHGLQRQHVXEMHFWEHFDXVHWKH
patch position was at the inferior vena cava. The 
defect closure rates for both groups were not signifi-
cantly different. 
There were no device- nor surgical-related 
deaths in either group. Complication rates were 
higher in the surgical closure group than in the 
transcatheter closure group, either during or post-
Table 3. Comparison of complications in the surgical closure and transcatheter closure groups
Complications
Procedures
P value OR (95% CI) Surgery
(n = 70)
ASO
(n = 42)
During procedure, n (%) 16 (23)   4 (9) 0.074 1.36 (1.03 to 1.8)
Post-procedure, n (%) 38 (54)   9 (21) 0.001 1.64 (1.24 to 2.18)
Total number of patients with complications, n (%) 42 (60) 12 (29) 0.001 1.61 (1.19 to 2.18)
Table 4. Type of complications found in each group 
Complications
Procedures
Surgery ASO
During procedure (total cases) 30 cases 5 cases
Major complications
Device  failed to deploy, requiring reintervention
Arrhythmias, requiring cardioversion
Arrhythmias, requiring reapplication of CPB machine
Bleeding, requiring blood tranfusion
  -
17
  2
  2
1
-
-
-
Minor complications
Arrhythmias, requiring conservative treatment
Hemodynamic instability
  6
  3
3
1
Post-procedure (total cases) 86 cases 9 cases
Major complications
Acute respiratory distress syndrome (ARDS) 
Device migration, requiring reintervention
Pericardial effusion, requiring drainage
Pleural effusion, requiring drainage
Bronchus hyperreactivity, requiring mechanical ventilation
Pulmonary bleeding
Pneumothorax, requiring drainage
Reoperation
  2
  -
  1
  1
  1
  1
  5
  1
-
1
-
-
-
-
-
-
Minor complications
Anemia
Arrhythmias, requiring conservative treatment
Atelectasis
Fever
Pulmonary edema
Pericardial effusion, requiring conservative treatment
Pleural effusion, requiring conservative treatment
Subcutaneous emphysema
Heart failure
Hemodynamic instability
Bronchial hyperreactivity 
Hypertension
Pulmonary hypertension crisis
Wound or puncture pain
Wound bleeding
Pneumomediastinum
Pneumonia
Pneumothorax, requiring conservative treatment
Weaken dorsalis pedis artery pulse
Sepsis
  5
10
  4
11
  1
  4
  1
  2
  2
  3
  5
  7
  1
  4
  1
  2
  4
  2
  -
  5
-
1
-
3
-
-
-
-
-
-
1
-
-
2
-
-
-
-
1
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procedure (Table 3). Table 4 summarizes the type 
RIFRPSOLFDWLRQVHQFRXQWHUHGE\WKHVXEMHFWV7KHUH
ZHUHFRPSOLFDWLRQVLQVXEMHFWVFRQVLVWLQJ
of 35 cases that occurred during the procedure and 
FDVHVWKDWRFFXUUHGSRVWSURFHGXUH)URPWKH
PDMRUFRPSOLFDWLRQVFDVHVRFFXUUHGLQWKHVXUJLFDO
closure group.
There was a significantly longer median length 
of hospital stays for the surgical group than for the 
WUDQVFDWKHWHUJURXS>UDQJHGD\VDQGUDQJH
GD\VUHVSHFWLYHO\3@$OOVXEMHFWVLQ
the surgical closure group required intensive care unit 
,&8VWD\VZLWKDPHGLDQOHQJWKRIUDQJHGD\V
DVFRPSDUHGZLWKRQO\VXEMHFWVLQWKHWUDQVFDWKHWHU
FORVXUHJURXSZKRUHTXLUHGWKH,&8ZLWKHDFKVXEMHFW
UHTXLULQJRQO\GD\3
The mean total patient charges for  transcatheter 
closure procedure was higher than that of surgery. 
Despite the lower cost of the procedure, supporting 
examinations, hospital stays, and medical fees for the 
transcatheter closure group, the pharmacy costs were 
higher than that of the surgery group, as the ASO
device was considered to be part of the pharmacy 
category (Table 5).
Cost calculation in the CMH Cardiology Center 
is a package system, which covers all expenses required 
for one surgical procedure or transcatheter procedure, 
hence the cost of the ASO is included in the pharmacy 
cost. Total cost analysis without the cost of device 
DSSUR[LPDWHO\5SUHGXFHGWKHPHDQ
total cost of the transcatheter closure procedure, 
making it less costly than the mean total cost of 
surgery (Table 5).
Discussion
Transcatheter closure of secundum ASD has 
become a feasible alternative to surgical closure. 
The ASO has many advantages including a self-
centering mechanism that leads to simple placement 
technique and better complete closure rates.
This retrospective study showed that transcatheter 
closure using ASO and surgical closure had similar 
successful closure rates, in agreement with previous 
reports that compared both procedures with closure 
UDWHUDQJHRI Both procedures were 
also similarly effective in reducing right ventricular 
dilatation at six month follow-up. Our surgical 
closure group had larger ASD diameters than that of 
the transcatheter closure group, also found in previous 
reports. These findings imply that larger defects 
may require surgery. However, Vida et al. found that 
their transcatheter closure group had larger ASD 
than that of the surgical closure group. Hence, both 
procedures can be equally useful in secundum ASD 
closure. Nevertheless, surgical intervention will still 
be required for patients with defects unsuitable for 
transcatheter closure.
,QRXUVWXG\RIVXEMHFWVLQWKHWUDQVFDWKHWHU
closure group had failed procedures. These failures 
were due to the large ASD size, inaccurate measure-
ment of ASD size, or undersizing of the device. Failure 
UDWHVKDYHEHHQUHSRUWHGWREHEHWZHHQ
Better screening for patients using transesophageal 
echocardiography with three-dimensional recon-
struction imaging and increasing operator experience 
would better identify patients who should not be 
Table 5. Comparison of patient charges between surgical closure and transcatheter closure
Patient charges
Procedures
P value Surgery
(n = 70)
ASO
(n = 42)
Mean procedure (SD), Rupiah   4,151,000 (2,356,000)   2,878,000    (935,000)   0.030
Mean pharmacy (SD), Rupiah 18,162,000 (4,327,000) 40,331,000 (5,576,000) <0.0001
Mean supporting examination (SD), Rupiah   2,152,000    (985,000)   1,118,000    (568,000) <0.0001
Mean hospital stay (SD), Rupiah    2,333,000 (1,763,000)      669,000    (444,000) <0.0001
Mean medical fees (SD), Rupiah 20,228,000 (5,168,000)   7,762,000 (4,669,000) <0.0001
Mean total cost (SD), Rupiah  46,995,000 (9,246,000) 52,732,000 (6,716,000) <0.0001
Mean total cost (without ASO cost) (SD), Rupiah 46,995,000 (9,246,000) 24,160,000 (8,982,000) <0.0001Mazdar Helmy et al: Comparison of surgical vs. non-surgical closure procedures for secundum atrial septal defect
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candidates for transcatheter closure and minimize 
the failure rates.
As the closure rate with transcatheter closure 
was identical to that of surgery, a comparison of pro-
cedures should focus on safety. The mortality in both 
groups was zero. However, the surgical closure group 
was at a higher risk for complications. Previous reports 
found that the number of complications was signifi-
cantly higher in the surgical closure group compared 
to that of the transcatheter closure group.
Arrhythmias were the most common complication 
in our study. Possible explanations could be heart 
muscle disturbance during the surgical procedure or 
stretching of the interatrial septum by the central 
waist of the device in the transcatheter procedure.
2WKHUFRPSOLFDWLRQVLQRXUVXEMHFWVLQFOXGHGIHYHU
pericardial effusion, anemia, and pneumothorax, 
which were also found in previous reports.
)XUWKHUPRUHZHIRXQGWKDWPRVWPDMRUFRPSOLFD-
tions occurred in the surgery patients. In previous 
UHSRUWVVXUJLFDOSURFHGXUHVKDGPDMRUFRPSOLFDWLRQ
UDWHVUDQJLQJIURPDVFRPSDUHGZLWKIRU
transcatheter procedure.
The number of days spent in the hospital was 
much higher in surgical closure group than in the 
transcatheter closure group, with a median difference 
in hospital stay of more than 3 days. These findings 
confirmed previously described results, in which surgery 
procedure patients spent 3-8 days in the hospital as 
FRPSDUHGZLWKGD\VIRUWUDQVFDWKHWHUSURFHGXUH
patients.$OOVXEMHFWVLQWKHVXUJLFDOFORVXUH
JURXSUHTXLUHGVWD\VLQWKH,&8IRUDWOHDVWGD\4XHN
et al.25 reported that all patients who underwent surgery 
ZHUHUHTXLUHGWREHLQWKH,&8IRUDWOHDVWGD\ZLWK
KDYLQJWRVSHQGGD\V6KRUWHUKRVSLWDOVWD\LQ
the transcatheter closure group was due to the simpler 
procedure, with fewer morbidities or complications, 
hence, patients required only regular ward care. On
the contrary, surgery patients required ICU stays to 
monitor complications after thoracotomies and usage 
of the cardiopulmonary bypass machine. These 
findings imply that children who undergo transcatheter 
closure could return to normal activities in a much 
shorter time and with less psychological trauma for 
both children and parents.
Our cost analysis showed that the mean total 
FRVWRIWKHWUDQVFDWKHWHUSURFHGXUHZDVPRUH
expensive than surgery. The ASO cost represented 
RIWKHWRWDOFRVWRIWKHWUDQVFDWKHWHUSURFHGXUH
and the percutaneous approach without the device 
cost was less expensive than the surgical procedure. 
This cost analysis was also found in a previous report 
that compared the costs of the two procedures for 
ASD closure without taking into account the cost 
of the device.  Vida et al. showed that the cost of the 
$62DOVRUHSUHVHQWHGDERXWRIWKHWRWDOFRVWRI
the transcatheter procedure.Based on this study and 
previous reports, the main areas of cost differences 
between the two groups were the high cost of the ASO
in the transcatheter group and longer hospital stay and 
higher pharmacy costs due to higher morbidity in the 
surgery group. We did not take into account 
non-medical or indirect costs due to the limited study 
design. However, those non-medical costs (family 
costs) could have a role in increasing the total cost of 
surgery. The economic cost of a family member’s time 
will have to be considered due to a patient’s longer 
recuperation period after surgery.
A limitation of this study was the retrospective 
design, since we used medical records as our data 
VRXUFH6RPHGDWDIURPPHGLFDOUHFRUGVRIVXEMHFWV
in the transcatheter closure group was incomplete, as 
seen in X-ray findings and electrocardiogram findings. 
7KHVHILQGLQJVFRXOGUHVXOWELDVWKDWVXEMHFWLQVXUJHU\
group had more severe problems. These fact should be 
confirmed with another study. Also, the 38 medical 
records which were not found could have led to a 
result bias. Another limitation was cost analysis by 
cost-minimization instead of cost-effectiveness, as 
most common cost analysis used in health policy 
evaluation. Cost-effectiveness analysis need unit 
cost calculation for every service product (procedure, 
pharmacy, supporting examination, hospital stay). 
Cost-minimization analysis compare total cost of both 
procedure directly, and the aim of this analysis is try 
to find procedure with minimal total cost and similar 
outcome. Hence, cost-minimization analysis was 
preferable due to our cost calculation system (package 
system) in the CMH Cardiology Center. 
In conclusion, we report here on the feasibility 
of transcatheter closure using Amplatzer® septal 
occluder as an alternative to surgery in secundum 
ASD closure patients. This transcatheter procedure 
is effective, with a closure rate similar to that of 
surgery, the standard therapy. Furthermore, the 
complication rate is lower and the length of hospital Mazdar Helmy et al: Comparison of surgical vs. non-surgical closure procedures for secundum atrial septal defect
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stay is shorter for transcatheter patients compare to 
those of surgical patients. There is no cost savings 
with the transcatheter closure as compare to cost of 
surgery, despite the shorter hospital stay, due to the 
high cost of the ASO device. However, the benefits 
for patients who undergo transcatheter closure, such 
as avoidance of thoracotomy and cardiopulmonary 
bypass, fewer morbidities, shorter hospitalization and 
DYRLGLQJSV\FKRORJLFDOWUDXPDDUHPDMRUDGYDQWDJHV
for patients and families. Additional studies with 
long-term follow-up are required to determine long 
term efficacy, morbidity, and the cost-benefit value 
in a larger number of patients. 
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